Yini iPioglitazone eyenzelwe yona
-Delile
IPioglitazone hydrochloride iyinto esebenzayo emithini elwa nesifo sikashukela ekhonjiswe ukuthuthukisa ukulawulwa kwe-glycemic kubantu abane-Type II Diabetes Mellitus, njenge-monotherapy noma ngokuhlangana neminye imithi, njenge-sulfonylurea, metformin noma i-insulin, lapho ukudla nokuvivinya umzimba kunganele ukulawula lesi sifo. Yazi ukuthi ungazibona kanjani izimpawu zesifo sikashukela soHlobo II.
IPioglitazone inegalelo ekulawuleni amazinga kashukela egazini kubantu abanesifo sikashukela sohlobo II, okusiza umzimba ukuthi usebenzise i-insulin ekhiqizwe ngempumelelo enkulu.
Lo muthi utholakala ngemithamo engu-15 mg, 30 mg kanye no-45 mg, futhi ungathengwa emakhemisi ngentengo emayelana ne-14 kuya ku-130 reais, ngokuya ngomthamo, usayizi wokupakisha kanye nomkhiqizo noma ama-generics akhethiwe.
Isetshenziswa kanjani
Umthamo wokuqala onconyiwe we-pioglitazone yi-15 mg noma i-30 mg kanye ngosuku, kuze kufike ku-45 mg nsuku zonke.
Isebenza kanjani
IPioglitazone isidakamizwa esincike ebukhoneni be-insulin ukuze sibe nomthelela futhi sisebenze ngokwehlisa ukumelana ne-insulin emaphethelweni nasesibindi, okuholele ekwandeni kokuqedwa kwe-glucose encike kwi-insulin kanye nokwehla ekukhiqizeni i-glucose yesibindi .
Ngubani ongafanele asebenzise
Lo muthi akufanele usetshenziswe kubantu abane-hypersensitivity to pioglitazone noma ezinye zezinto zefomula, kubantu abanomlando wamanje noma owedlule wokuhluleka kwenhliziyo, isifo sesibindi, i-ketoacidosis yesifo sikashukela, umlando wesifo somdlavuza wesinye noma ukuba khona kwegazi emchameni.
Ngaphezu kwalokho, i-pioglitazone akufanele futhi isetshenziswe kwabesifazane abakhulelwe noma kwabesifazane abancelisa ibele ngaphandle kwezeluleko zezokwelapha.
Imiphumela emibi engaba khona
Imiphumela emibi kakhulu engahle yenzeke ngesikhathi sokwelashwa nge-pioglitazone ukuvuvukala, ukukhuphuka kwesisindo somzimba, amazinga we-hemoglobin anciphise ne-hematocrit, ukwanda kwe-creatine kinase, ukwehluleka kwenhliziyo, ukungasebenzi kwesibindi, i-edema ye-macular kanye nokuvela kwamathambo kwabesifazane.